Skip to content

Neurological side-effects of efavirenz mild and transient, study claims

HIV treatment reduces risk of TB in South Africa more than previously thought

Pfizer releases further details of liver toxicity in maraviroc study

Hospitalisations and deaths down in US, slight increase in number of admissions due to liver problems

Ranbaxy announces new co-packaged triple ART combinations

Interleukin-2 has short-lived negative impact on quality of life

Tipranavir continues to show benefit in treatment-experienced patients after one year

Many people with drug-resistant HIV having unprotected sex

Bone problems caused by HIV and duration of anti-HIV treatment